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ABSTRACT

Obesity is a serious and costly condition, causing a higher prevalence of chronic diseases
and having an average medical cost of $1,430 higher than non-overweight patients (Finkelstein,
Trogdon, Cohen, & Dietz, 2009). With more than two thirds of U.S. adults suffering from
overweight or obesity, health organizations have recognized the disease as a threat to the wellbeing of the nation. In 2013, the American Health Association (AHA) and the American College
of Cardiology (ACC) among other stakeholders developed a set of guidelines and
recommendations for primary health providers in order to reduce overweight, obesity and
concomitant conditions (Jensen et al., 2014). The evidence-based guidelines suggest the elements
of weight loss lifestyle interventions that have been proven to result in clinically meaningful
health benefits for patients. Nevertheless, the guidelines also report the gaps in evidence, such as
the need to understand and improve the efficiency of on-site lifestyle interventions on key
populations including racial/ethnic groups.
The overall goal of this study was to assess weight and blood pressure changes of
Hispanic adult participants who engaged in a Promotora-Led Mi Corazon Mi Comunidad
(PLMM) intervention. A total of 753 participants were initially enrolled in the intervention
conducted from 2009 – 2013 in El Paso, Texas. The 2013 AHA/ACC/TOS Guideline was used
as a reference to assess weight and blood pressure changes between pre- and post-intervention.
The specific aims of the study were: 1) to identify participants who upon enrollment met 2013
AHA/ACC/TOS Guideline cut-off points for overweight and obesity; 2) to identify participants
who in addition to meeting the overweight and obesity criteria, also met the cut-off points for
waist circumference in the 2013 AHA/ACC/TOS Guideline (n=500); 3) to determine the
proportion of female and male participants who achieved 3, 5 and 10 percent weight reduction
v

milestones consistent with recommendations from the 2013 AHA/ACC/TOS Guideline after the
4-month intervention, and 4) to determine blood pressure changes in female and male
participants who completed the PLMM intervention (n=285).
Results from secondary data analyses indicated that 57% of eligible participants were
retained after the 4-month intervention. The 285 participants that completed the intervention
achieved an average weight loss of 1.48% ±3.33. The median weight loss of 1.31±3.3 kg was
statistically significant (p=0.001), which represents a 0.5±1.29 kg/m2 (p=0.001) decrease in
overall BMI measurements. In addition, there was a statistically significant reduction of 3.32 ±
6.38 cm (p=0.001) in waist circumference, a measurement strongly associated with
cardiovascular health risk. Diastolic and systolic blood pressure were also reduced by 0.59 and
0.84 mmHg respectively among the selected sample of participants. A total of 28% of the 285
selected participants that completed the PLMM achieved a body weight loss of 3% or more,
which according to the 2013 AHA/ACC/TOS Guideline will produce clinically meaningful
health benefits.
In conclusion, the 4-month intervention led by Community Health Workers/Promotores
de Salud proved to be an efficient method to reduce overweight and obesity among Hispanic
adults living in El Paso, TX. The inclusion of an individualized diet component and increase in
the intervention time to 6 months or more could further improve the health benefits achieved by
the PLMM intervention
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INTRODUCTION

Obesity is considered one of the top three most urgent health concerns in the United
States (U.S.) (Gallup poll, 2014). The prevalence of overweight and obesity has been
progressively rising over the last 40 years and is currently at unprecedented levels, when
combined, more than 68.0% of US adults are considered above normal weight and 33.8% are
obese (Flegal, Carroll, Ogden, & Curtin, 2010). There are significant economic costs associated
with obesity. According to Finkelstein et al., in 2010 the total medical cost of obesity, now
considered a disease, was approximately 73.1 billion dollars. Medical and health care
communities consider obesity as a multifactorial disorder caused by various contributing factors
such as genetics, environment, and lifestyle. Therefore, a comprehensive lifestyle intervention
comprised of physical activity, diet and behavioral therapy has a higher possibility to succeed in
promoting and maintaining weight loss (Pagoto & Appelhans, 2013). Comprehensive lifestyle
interventions are important tools to address disparities in the prevalence of overweight and
obesity in the population. For instance, when compared to the US population individuals from
Hispanic descent are disproportionately affected by overweight and obesity. In 2013, the
American Heart Association (AHA), American College of Cardiology (ACC) and The Obesity
Society (TOS) developed a set of guidelines and recommendations based on high quality
randomized trials, meta-analyses and observational studies (Jensen et al., 2013). There is a lack
of information about obesity lifestyle interventions for Hispanics living in the U.S.-Mexico
border incorporating the 2013 AHA/ACC/TOS overweight and obesity guideline. The 2013
AHA/ACC/TOS Guidelines recognized that research is needed to better understand and improve
the efficiency of on-site lifestyle interventions on key populations including racial/ethnic groups.
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The objective of this study was to conduct a secondary data analysis from the cross-sectional
data collected in the Promotora-Led Mi Corazón Mi Comunidad Intervention (here on forward
PLMM) implemented in Hispanic adults from 2009 to 2013 living in El Paso, Texas that
compared its clinical outcomes to the 2013 AHA/ACC/TOS Guideline for the Management of
Overweight and Obesity in Adults. The PLMM intervention was implemented in less time than
what the 2013 AHA/ACC/TOS guidelines recommend. However, the intervention applied a high
number of physical activity sessions and nutrition education and was implemented by
Community Health Workers (CHW)/Promotores de Salud (PS). This study only evaluated the
clinical outcomes of overweight and obese participants and identified those who achieved the
recommended 3-5% weight loss according to the 2013 AHA/ACC/TOS Guideline after the
intervention was completed. The study also evaluated the effectiveness of CHW/PS to deliver
weight loss lifestyle interventions to Hispanic community. Potential results from this study are
stated as gaps of evidence and future research essentials in the 2013 AHA/ACC/TOS Guidelines.
The guidelines recognized the need for studies focusing on improvements in efficacy, optimizing
dissemination and targeting special populations. The 2013 report emphasizes that further
research is needed to better understand and improve the efficiency of on-site lifestyle
interventions (14 or more contact sessions) on key populations including racial/ethnic groups
(Jensen et al., 2013). Furthermore, the gaps in evidence require studies that can be delivered in
the community as opposed to academic settings and to determine the adequate skills and personal
characteristics required to serve in lifestyle interventions.
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CHAPTER 1: BACKGROUND AND SIGNIFICANCE
1.1 Overweight and Obesity
Overweight and obesity are serious conditions defined as excessive fat accumulation in
the adipose tissue that is adversely associated with health. This abnormal fat accumulation in
humans is considered a complex disorder caused by hereditary and environmental factors that
disturb the energy balance (Buttar, Li, & Ravi, 2005). This unbalance is usually caused by a
high dietary intake that surpasses the energy expenditure. There are highly efficient methods to
calculate total body fat such as bioelectrical impedance and dual-energy X-Ray absorptiometry.
However, these methods are often expensive and not universally available. In addition, the
previously mentioned methods lose accuracy on severely obese individuals. One of the most
common measurement that are used internationally to classify overweight and obesity in adults is
Body Mass Index (BMI). BMI is calculated using the person's weight [kg] divided by the square
of their height [m2] (Eknoyan, 2008). According to the 1998 Clinical Guidelines on the
Identification, Evaluation, and Treatment of Overweight and Obesity in Adults (The Evidence
Report) and the World Health Organization (WHO), overweight is defined as a condition when
people have a BMI equal or greater than 25 kg/m2 and obesity is consistent with a BMI equal or
greater than 30 kg/m2 (NHLBI, 1998; WHO, 2014c) (Table 3). BMI is a valuable tool for health
care practitioners since it is an inexpensive and universally available method that correlates
weight with total body fat on a population basis.
1.1.1 Health Consequences Associated with Overweight and Obesity
Overweight and obesity are associated with a higher incidence of cardiovascular disease
(CVD), liver disease, dyslipidemia, and certain types of cancer (Mozaffarian et al., 2015). The
3

harmful health consequences of weight gain extent from non-fatal reduction of quality of life to
increased risk of premature death. Obesity is considered a major risk factor for type 2 diabetes
given that 80% of patients diagnosed with the disease are overweight or obese (Smyth & Heron,
2006). In addition, in a systematic review of 57 prospective studies, the presence of obesity is
directly proportional to risk of death after adjusting for smoking status (Prospective Studies
Collaboration, 2009).
The non-fatal health problems associated with obesity include skin problems, respiratory
difficulties, infertility and chronic muscular-skeletal problems. Obesity has been recognized as a
key risk factor for the development of other chronic and non-communicable diseases. When
compared to normal weight adults, obese persons have an overall increased risk of death for allcauses of death, low quality of life, and serious health conditions. The following conditions have
been linked to obesity: hypertension, dyslipidemia (high Low-Density Lipoprotein (LDL)cholesterol and low High-Density Lipoprotein (HDL)-cholesterol, or high levels of
triglycerides), type 2 diabetes, coronary heart disease, stroke, gallbladder disease, osteoarthritis,
sleep apnea and breathing problems. In addition, obesity is a risk factor for some cancers
(endometrial, breast, colon, kidney, gallbladder, and liver), reproductive hormone abnormalities
(polycystic ovary syndrome), mental illness (clinical depression, anxiety, and other mental
disorders), body pain, difficulty with physical functioning and low back pain (Mozaffarian et al.
2015; NHLBI, 2013; CDC, 2015; Bhaskaran et al. , 2014). Lastly, it has been reported that
individuals with higher BMI independent of age and gender, have a 30% increment rate for allcause mortality. Increments of 5 kg/m2 over the normal BMI range (25 kg/m2) signify additional
risk for vascular disease (40%), as well as for diabetes, renal and hepatic disease (60-120%) and
other conditions (Prospective Studies Collaboration 2009).
4

1.1.2 Overweight and Obesity Prevalence
Worldwide, overweight and obesity are recognized as a serious and rapidly growing
threat to the health of the world’s population. The prevalence of this health condition knows no
boundaries, having an impact on developing and developed countries alike. Globally, 39% of
adults 18 years or older are overweight while 13% are classified as obese (WHO, 2014). In
2012, more than two-thirds (68.5%) of U.S. adults age 20 and older were considered either
overweight or obese (NIH, 2012). Obesity is estimated to affect more than one-third (34.9%) of
the adult population with an occurrence of 6.4% for extreme obesity (BMI of 40 or more) (NIH,
2012; Ogden, Carroll, Kit & Flegal, 2014). Among Americans 71.3% of men and 65.8% of
women were classified as overweight or obese, while 33.5% of men and 36.1% of women were
obese. The State of Obesity website (2014) ranks Texas at the 11th place for adult obesity in the
U.S. The impact obesity is having on world health has encouraged many researchers and health
practitioners to characterize the condition as a disease. Accordingly, in 2008 and 2013, the
Obesity Society (Allison et al. 2008) and the American Medical Association (Pollack 2013)
respectively, expanded their classification of obesity from being a risk factor to disease.
Although this reclassification has no legal authority and is opposed and criticized by many (Katz
2014, Stoner & Cornwall 2014); the objective of these association was to increase awareness,
reduce the stigma of obesity and potentially pave the way to facilitate insurance reimbursement
for obesity medications, surgery, and counseling (Pollack 2013).
1.1.3 Economic Cost of Overweight and Obesity
The economic impact associated with overweight and obesity for a country is significant.
Direct medical cost is represented by the medical diagnosis, prevention, and treatment of obesity;

5

while indirect costs include economic loss from work absenteeism or decrease in productivity. In
2010 it was estimated that globally, overweight and obesity caused 3.4 million deaths, 3.8% of
disability adjusted life years (DALYs) and 3.9% of years of life lost (Ng et al., 2014).

Figure 1. Total U.S. obesity costs (Algazy, Gipstein, Riahi, & Tryon, 2010).

The McKinsey report published in 2010 indicated that 160 billion dollars were spent in
direct medical costs associated with obesity in the U.S. (Figure 1). The report estimates that the
overall cost of obesity is 450 billion dollars in the U.S. alone (Algazy, Gipstein, Riahi, & Tryon,
2010).
6

1.1.4 Causes of Overweight and Obesity
The cause for overweight and obesity is more complex than an energy unbalance. Many
factors such as environmental, behavioral, and genetic factors as well as medical conditions
contribute in varying degrees to overweight and obesity (Aronne, Nelinson, & Lillo, 2009; Faith
& Kral, 2006). Behavioral factors (e.g. poor diet, inactive lifestyle, lack of sleep) affects adults
and children alike and have become a leading public health concern given that it adds
substantially to the burden of chronic health conditions (WHO, 2014b). It has been suggested
that factors in the everyday environment promote these behaviors. High calorie processed food
products are heavily marketed and readily available in the communities. In addition, these
products are consistently cheaper than more nutrient dense foods (Rao, Afshin, Singh, &
Mozaffarian, 2013; Andrieu, Darmon & Drewnowski, 2006). Physical activity can help reduce
the burden of overweight and obesity as well as many of its associated chronic diseases.
However, despite all the health benefits, physical activity levels have been declining worldwide,
mostly due to the adoption of sedentary behaviors of modern life such as increased working
hours, television watching, internet, video games, etc. (WHO, 2011). Other factors such as
socioeconomic status (SES) and education have shown to have an influence on obesity.
According to Wang & Beydoun (2007), the SES has an influence on obesity and it varies by
ethnicity; however, the ethnic differences in obesity are not fully explained by SES alone. It has
been recognized that education plays a role on obesity. In 2007, Wang and Beydoun analyzed the
National Health and Nutrition Examination Survey (NHNES) data and reported that the
prevalence of obesity is higher among less educated people in the U.S., with the exception of
black woman. On the other hand, the Centers for Disease Control and Prevention (CDC) reported
no trend between obesity and education among man (Ogden, Lamb, Carroll, & Flegal, 2010).
7

Interestingly, in the same study, a significant trend shows that educated women are less likely to
be obese compared with less educated women (Ogden, Lamb, Carroll, & Flegal, 2010).
1.1.5 Overweight and Obesity among Hispanics
The Hispanic population is the largest minority group in the U.S. and one of its fastest
growing ethnic groups. Currently, 17 % of the U.S. population is Hispanic and this number is
expected to reach 31% by the year 2060 (Krogstad, & Lopez, 2014). Studies have found
racial/ethnic differences in the prevalence of obesity with Hispanics and non-Hispanic blacks
having the highest age-adjusted rates when compared to non-Hispanic whites and non-Hispanic
Asians (Ogden, Carroll, Kit, & Flegal, 2012). During 2011-2012 it was reported that 42% of
Hispanics were obese surpassed only by non-Hispanic blacks with 47.8% while Asians and
whites had obesity rates of 10.9 and 33.4 respectively (Ogden, Carroll, Kit, & Flegal, 2012). The
prevalence of class 3 obesity followed a similar trend with percentages of 12.1, 5.8, 5.6 and 0.9
for Black, Hispanic, White and Asian respectively (Ogden, Carroll, Kit, & Flegal, 2014). Ogden
et al (2014) reported that 16.9% of youth (2 to 19 years old) in the U.S. were obese. Hispanic
youth had the highest obesity prevalence with 22.4 % when compared to youth from Asian
(8.6%), Black (20.2%) and White (14.1%) ethnicities (Ogden, Carroll, Kit, & Flegal, 2014). The
occurrence of obesity among the Hispanic population creates further disparities when associated
to chronic diseases; 13.2 % of Hispanics adult are affected by diabetes compared to the 7.6%
from the white counterparts. In addition, Hispanics suffer 43% more from stroke than persons
from white ethnicity (Schiller, Lucas, Ward, & Peregoy, 2012).
The obesity and overweight disparity among different ethnic groups has been attributed
to several causes that contribute to the problem. In the U.S., there is a well-known association
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between SES and obesity as previously mentioned varies by ethnicity (Wang & Beydoun, 2007).
In the U.S. people with higher SES were less likely to be obese (Wang, 2001; Wang & Beydoun,
2007). The previous statement is true for people of white ethnicity; however, reports have shown
that among Hispanic youth there is no significant trend in obesity prevalence by income level
(Ogden, Lamb, Carroll & Flegal, 2010). It is worth mentioning that in lower income countries,
people with higher SES had higher prevalence for obesity (Dinsa, Goryakin, Fumagalli &
Suhrcke, 2012). Accordingly, SES is not the sole reason for the prevalence of obesity in the
Hispanic community, but multiple causes contribute to the disparity. Hispanic acculturation and
generational status mainly via associations with diet and physical activity have been linked to
obesity (Ayala, Baquero, Klinger, 2008). Corral et al. (2014) stated that Hispanic people
preferred to live in residential areas that have their same ethnicity. The authors highlighted that
these neighborhoods usually have a decreased number of recreational facilities and a higher
number of fast food outlets than white neighborhoods with similar SES; thus suggesting that
segregated Hispanic neighborhoods promote an environment conducive of obesity (Corral,
Landrine & Zhao, 2014).

1.2 Benefits of Weight Loss
The adverse effects of overweight and obesity are evident given their strong association
with chronic diseases and mortality. Many studies have been conducted to elucidate whether
weight loss can reverse the adverse health outcomes caused by obesity (e.g. diabetes, CVD etc.).
Studies reported by Jensen et al. (2014) have found that weight loss consistently reduces the risk
of developing type 2 diabetes in at risk populations (e.g. obese and overweight individuals). The
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authors concluded that weight losses of 2.3 to 5.5 Kg at 2 or more years in individuals at risk for
type 2 diabetes reduces the risk of developing the disease by 30 to 60 % (Jensen et al., 2014,
p3001). Overall, it has been documented that individuals with a BMI within normal range (18.5 –
24.9kg/m2) had the lowest mortality rate when compared to individuals with higher BMIs and
adjusting for smoking (Prospective Studies Collaboration, 2009). There are some reported
weight loss risks in the literature such as cholelithiasis or gallbladder disease (Stinton & Shaffer,
2012). Furthermore, it is widely recognized that weight loss results in higher fertility rates and
improves reproductive outcome (Clark, Thornley, Tomlinson, Galletley, & Norman, 1998).
Nonetheless, the risks are overshadowed by weight loss improved health outcomes and improved
quality of life.
1.2.1 Weight Loss and Lifestyle Interventions
The “Look AHEAD (Action for Health in Diabetes)” study provided insights on weight
loss health outcomes in patients who were diagnosed with type 2 diabetes. The study lasted
eleven years and included 5,145 participants. The study was designed to identify the intentional
weight loss effects on cardiovascular morbidity and mortality in individuals with type 2 diabetes
(Bray, 2006). The authors reported that individuals with type 2 diabetes who achieved a 2 to 5 %
weight loss during 1 to 4 years presented reductions in fasting plasma glucose concentration and
glycated hemoglobin (HbA1C). In addition, the “Look AHEAD” study found that individuals
with type 2 diabetes who underwent a change in lifestyle to reduce obesity regained about 8% of
the weight initially loss after 4 years. However, their HbA1C levels remained below preintervention levels despite the partial increase in weight.
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It has been documented that many patients that initiate dietary interventions usually
regain weight after the intervention has ended. The main cause for weight regain is the nonobservance of the diet due to boredom or lose of interest. This has caused many overweight and
obese patients to constantly look for a better diet to lose weight. The study by Pagoto and
Appelhans (2013) showed that weight loss was strongly associated with adherence to a program
rather than to a type of diet. The authors concluded that in order to challenge the obesity
epidemic a greater understanding of the factors (environmental, biological, and behavioral)
associated with adherence to a lifestyle change need to be addressed (Pagoto, & Appelhans,
2013). Therefore, a comprehensive lifestyle intervention comprised of physical activity, diet and
behavioral therapy has a higher possibility to succeed in promoting and maintaining weight loss.
1.2.2 Community-Based Participatory Research Interventions
Community based participatory research (CBPR) is an approach to health research that
integrates education and social action to address health disparities problems in a population.
CBPR incorporates community theories and fosters communication between the stakeholders to
benefit community participants, researchers and health care practitioners alike (Wallerstein &
Duran, 2006; Viswanathan et al., 2004). In addition, it is recognized that structural, socioeconomic, and racial/ethnic health inequities are well approached by CBPR through
collaborative partnerships within the community (Muhammad et al., 2015).
Strategies of CBPR have been used to understand problems in specific areas and identify
possible interventions. Goh and collaborators (2009) explored adolescent, parent, and
community focus groups regarding the perspectives on barriers to healthy eating and physical
activity with the overall aim to identify intervention ideas to address adolescent obesity. The
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research recognized the CBPR value in finding potential interventions that are accepted by the
community (Goh et al., 2009).

1.3 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity
In 2013, a panel representing experts from the American Heart Association (AHA),
American College of Cardiology (ACC) and The Obesity Society (TOS) among other
stakeholders developed a set of guidelines and recommendations for primary healthcare
providers in order to manage blood cholesterol and reduce cardiovascular risk, as well as
overweight and obesity in adults. The objective of stakeholders in the panel was to develop
evidence-base statements and recommendations to assist health providers in identifying and
managing overweight and obese adults at health risk. The aim of these guidelines was to create
practices that fulfill the needs of the majority of the patients. Some of the key findings from high
quality evidence review are presented in Table 1.
The 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in
Adults were based on high quality randomized trials, meta-analyses and observational studies by
a panel of experts on each subject, only when sufficient evidence was available. The overall
objective of these guidelines is to assess the risk for CVD and reduce the onset of the disease by
encouraging people who are at risk to engage in lifestyle modifications.
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Table1. Key Messages Adapted from the 2013 Obesity Guideline and Differences from the 1998
Obesity Guidelines (Kushner & Ryan, 2014).

Key Messages

Who needs to lose
weight?
What is the role of
waist circumference?
How much weight
loss must be
achieved?

2013 AHA/ACC/TOS Guidelines for
managing Overweight and Obesity in
Adults

Difference from 1998
NHLBI Guidelines

BMI≥30 or BMI≥25 with ≥ 1 risk factor
(including waist circumference, traditional risk
factors)
Use NIH/NHLBI and WHO/IDF cut points
(≥35 in. for women and 40≥ in. for men) to
further identify risk
Not necessary to achieve ideal BMI
Sustained weight loss of 3%-5% produces
clinically meaningful health benefits and
greater loss produces greater benefits

Positions BMI as a screening tool,
not a diagnostic tool

What is the best
diet?

There is no “magic” diet for weight loss
Prescribe a calorie-reduced diet based on the
patient’s health profile and food preferences

How much weight
can be lost with
lifestyle
intervention?
Are there
alternatives to inoffice counseling?

The ideal is 14 or more face-to-face counseling
sessions with a trained interventionist in the
first 6 months with treatment for 1 year to
produce average 8% weight loss

How can weight loss
be maintained?

Who should receive
bariatric surgery

Telephonic counseling, electronic counseling,
and commercial programs have an evidence
base for efficacy, albeit with less average
weight loss than face-to face counseling
Continue regular contact (monthly or more)
with a trained interventionist who helps
patients engage in high levels of physical
activity (ie, weekly or more), and consume a
reduced-calorie diet
For adults with BMI≥40 or BMI≥35 with
obesity-related comorbidities who have not
responded to treatment, advise that bariatric
surgery may be an appropriate option and offer
referral to an experienced bariatric surgeon

Waist circumference is treated as a
risk factor in 2013 guidelines
Greater emphasis on benefits of
modest weight loss and
importance of maximizing weight
loss but does not suggest a BMI
target
Does not endorse any particular
dietary approach because all
approaches can succeed if
accompanied by calorie deficit
Sets a standard for what a lifestyle
intervention should look like, who
should deliver it, and what it
should aim for
Reflects societal changes in
delivery of weight loss
intervention
Addresses importance of
continued therapy to prevent
regain

Stronger endorsement for referral
for bariatric surgery using the
same BMI and health criteria as
1998 guidelines

BMI: body mass index; IDF: International Diabetes Federation; NHLBI: National Heart Lung and Blood Institute;
NIH: National Institutes of Health; WHO: World Health Organization.
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The recommendations are categorized based on the level of evidence available,
consequently a “Grade A” recommendation would mean that based on scientific evidence there
is a high confidence of a substantial benefit. Whereas a “Grade C” recommendation would mean
that there is a low evidence that the recommendation provides a small benefit toward the overall
goals (Table 2). Nevertheless, “Grade B or C” does not mean that the recommendation is weak
simply that studies are unavailable.
Table 2. Strength of Recommendation Adapted from the 2013 AHA/ACC/TOS Obesity
Guideline. (Jensen et al., 2014).
Grade
A
B

C
D

E

N

Strength of Recommendation
Strong recommendation
There is high certainty based on evidence that the net benefit* is substantial.
Moderate recommendation
There is moderate certainty based on evidence that the net benefit is moderate to
substantial, or there is high certainty that the net benefit is moderate
Weak recommendation
There is at least moderate certainty based on evidence that there is a small net benefit
Recommendation against
There is at least moderate certainty based on evidence that it has no net benefit or that
risks/harms outweigh benefits
Expert opinion (“There is insufficient evidence or evidence is unclear or conflicting,
but this is what the Panel recommends.”)
Net benefit is unclear. Balance of benefits and harms cannot be determined because of no
evidence, insufficient evidence, unclear evidence, or conflicting evidence, but the Panel
thought it was important to provide clinical guidance and make a recommendation. Further
research is recommended in this area
No recommendation for or against (“There is insufficient evidence or evidence is
unclear or conflicting.”)
Net benefit is unclear. Balance of benefits and harms cannot be determined because of no
evidence, insufficient evidence, unclear evidence, or conflicting evidence, and the Panel
thought no recommendation should be made. Further research is recommended in this area.

*Net benefit is defined as benefits minus risks/harms of the service/intervention.
The guidelines were endorsed by the American Association of Cardiovascular and
Pulmonary Rehabilitation, American Pharmacist Association, American Society for Nutrition,
American Society for Preventive Cardiology, American Society of Hypertension, Association of
Black Cardiologists, National Lipids Association, Preventive Cardiovascular Nurses Association,
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and The Endocrine Society and WomanHeart: The National Coalition of Woman with Heart
Disease.
1.3.1 Recommendation for Body Mass Index
With a “grade A” level of confidence the 2013 AHA/ACC/TOS Guideline recommend to
use a BMI range from 25 to 29.9 kg/m2 to classify overweight and a BMI cut-off point of 30
kg/m2 and higher to classify obesity in adult individuals who could be at high risk of CVD
(Table 3). It is also recommended to use BMI≥30 as an indicator to identify adult individuals
with potential high risk of mortality.
The guidelines recognize the shortcomings of using BMI as a rubric to measure
overweight and obesity. BMI presents limitations in predicting the body fat association with
health risk on an individual basis. For instance, abdominal fat is associated with superior health
risk than fat located in other regions of the body; however, BMI measurements cannot
differentiate the distribution of body weight. Another limitation of BMI is that when life style
interventions are applied, this measurement is not an accurate indicator of an improved health
outcome, sometimes causing disappointment and diet and exercise regimens abandonment. Ross
and Janiszewski (2008) reported that physical activity was strongly associated with reductions in
coronary heart disease independent of weight or BMI. The authors concluded that an apparent
lack of weight loss should never be a reason to stop healthy behaviors (Ross & Janiszewski,
2008).
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1.3.2 Recommendation for Waist Circumference
To account for BMI measurement limitations, the guidelines suggest to measure waist
circumference (WC) with a “grade E” level of confidence in adult individuals with BMI
classifications at overweight and obese levels. Many authors recommend measurement of the
WC when predicting obesity health outcomes, since it accounts for the abdominal fat that is
strongly associated with metabolic syndrome (Booth, Hunter, Gore, Bauman, & Owen, 2000;
Rexrode et al., 1998; Zhu et al., 2002; Després & Lemieux 2006). Moreover, according to the
World Health Organization (WHO) obesity report (1998), if the documentation of the WC were
standardized as a measurement of abdominal fat accumulation over time, the health burden of
obesity would be easier to predict. Abdominal fat is associated with health risks such as organ fat
infiltration, pro-thrombotic and pro-inflammatory conditions (Van Gaal, Mertens, & Christophe,
2006; Jensen et al., 2014). However, there is debate among health organizations about the WC
cut-off points that relate to an elevated risk.
The National Institutes of Health (NIH) provide guidelines to classify obesity (Table 3) in
which BMI and WC are used (Booth, Hunter, Gore, Bauman, & Owen, 2000). These guidelines
recommend that patients with a BMI of 25 to 34.9 kg/m2 and WC greater than 102 cm (40 in) for
men and 88 cm (35 in) for woman are associated with a higher risk for type 2 diabetes,
hypertension, and coronary heart disease.
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Table 3. “Classification of overweight and obesity by BMI, waist circumference, and associated
disease risk” Adapted from the World Health Organization (Aronne, 2002).

*Disease risk for type 2 diabetes, hypertension, and coronary heart disease.
**Increased weight circumference can also be a marker for increased risk even in
persons of normal weight.

Although there is a lack of consensus between health agencies (e.g. WHO, NIH,
International Diabetes Federation) regarding the WC risk cutoff points, studies have presented
unequivocal evidence that supports a linear correlation between WC and health risks (de Koning,
Merchant, Pogue, & Anand, 2007; Vazquez, Duval, Jacobs, & Silventoinen, 2007; Emerging
Risk Factors Collaboration, 2011). Therefore, it has been suggested that BMI data in
conjunction with WC can provide a better health risk assessment of the patient than BMI alone
(Rexrode et al., 1998 & Janssen, Katzmarzyk, & Ross, 2002).
1.3.3 Guidelines for Overall Dietary Composition
One of the primary objectives regarding the treatment and prevention of obesity is to
identify patients at risk and implement weight loss interventions. Health providers play a key
role in these interventions given that they will promote dietary strategies that must be effective
and adequate for each patient. The common denominator between all dietary plans to tackle
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obesity is the need to alter the energy balance in the patient by creating an energy deficit.
Accordingly, there must be a reduction in energy intake from food since it is very difficult for
most overweight and obese patients to create an energy deficit by physical activity alone. Based
on strong evidence (Grade A), the 2013 AHA/ACC/TOS Guideline recommends any of the
following methods to reduce caloric intake. Prescribe a diet with specific energy intakes of 12001500 kcal/day for woman and 1500-1800 kcal/day for man, where the adjusted target of energy
intake should be less than the required for energy balance. It recommends the use of evidence
based diet approaches that restricts certain food types to create an energy deficit. Prescription of
a diet with an energy deficit of 500 to 750 kcal or 30% energy deficit after the patient daily
energy requirement and physical activity levels are calculated (Jensen et al., 2014). Most
importantly, the guidelines suggest diets for weight loss as part of a comprehensive lifestyle
intervention.
Interestingly, a metadata study reported that obese and overweight adults under dietary
intervention achieve an average maximum weight loss at 6 months with smaller losses
maintained for up to two years (Jensen et al., 2014). The studies did not investigate the causes for
weight regain after an initial intervention, nevertheless the authors suggest that loss of interest
and commitment as well as metabolic adaptation could be the causes.
Over time, adjustments to the diet must be made to achieve a continued weight loss
because the energy requirements will decrease as patients lose weight. Jensen et al. (2014)
studied the metadata from twelve trials with different dietary interventions and concluded that all
different dietary approaches can promote weight loss when reduction in energy intake is
achieved. In addition, the authors reported that when compared to an energy deficit diet, none of
the dietary approaches mentioned in the guidelines offered a superior performance. The study
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also concluded that further large scale research on optimal dietary patterns that include high and
no risk populations is needed in order to provide overweight management guidelines.
1.3.4 Guidelines for Weight Loss Intervention
By comparing lifestyle interventions with usual diet groups, ten randomized controlled
trials were analyzed by the 2013 AHA/ACC/TOS Guideline to validate that physical activity,
diet and behavioral therapy are essential components in comprehensive lifestyle interventions in
order to succeed with weigh loss promotion or maintenance (Jensen et al., 2014). The 2013
Guideline recommend for overweight and obese patients to engage in comprehensive lifestyle
interventions that include behavioral strategies that increase the individual’s adherence to a low
calorie diet and increase physical activity.. Based on strong evidence (Grade A), the 2013
guideline recommends that three components are included in effective comprehensive-lifestyle
intervention; 1) calorie intake reduction, 2) increase physical activity and 3) the use of behavioral
modification strategies. In addition, it is recommended that weight loss interventions should be
provided on-site and with a large number of sessions (i.e. 14 or more sessions are suggested) by
a trained interventionist. For overweight and obese individuals who have lost weight, the
guidelines recommend long-term (i.e. one year or more) weight loss maintenance programs
(Jensen et al., 2014).
Apart from diet, comprehensive interventions prescribe aerobic activity to increase the
energy expenditure; some studies recommend more than 150 minutes of brisk walking per week
(Jensen et al., 2014). Behavior therapy is a key aspect in any comprehensive lifestyle
intervention since it provides the patient with a set of skills that help them maintain the modified
eating and physical activity behaviors. Self-monitoring of food intake, physical activity and body
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weight is often recommended in behavior therapy (Jensen et al., 2014). Often, studies add
different components to the behavior therapy such as slow rate eating, problem solving and
relapse prevention.
Strong evidence (Grade A) suggests that better results are achieved when the duration of
the program is beyond 6 months. The studies (Jensen et al., 2014) concluded that lifestyle
interventions with frequent on-site group or individual treatment produced an average weight
loss of 8 kg in 6 months (approx. 5%-10% body weight reduction), which are greater than those
produced by usual care. The guidelines report with a high degree of certainty (Grade A) that
even minor, weight losses of 3-5% are expected to result in clinically meaningful health benefits
(i.e. reduction of triglycerides, blood glucose, HbA1C and the risk to develop type 2 diabetes).
The 2013 AHA/ACC/TOS Guideline also reports the relationship between weight loss and
hypertension risk. The guidelines report that with at a weight loss of 5% or more, a mean
reduction of 3 and 2 mm Hg is observed in systolic and diastolic blood pressure respectively.
In summary, the 2013 AHA/ACC/TOS Guideline indicates that comprehensive lifestyle
interventions with frequent patient contacts had the highest average weight loss at 6 to 12
months, after which a weight increase of 1 to 2 kg per year is associated (Jensen et al., 2014).
Nevertheless, long-term weight loss (i.e. over 12 months) in lifestyle interventions remains more
successful than regular care (Pi-Sunyer et al., 2007; Jensen et al., 2014).
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1.4 Healthy People 2020 Goals Related to Overweight and Obesity
Healthy People is a national wide heath agenda originally created in 1979 and generated
by the U.S. Department of Health and Human Services though the Office of Disease Prevention
and Health Promotion. The ultimate goal of Healthy People 2020 (HP 2020) is to attain a society
with high-quality and longer lives (free of preventable diseases, disability, injury, premature
death), and reach health equity, as well as improve health among all groups of people living in
the U.S. To attain its goals, Healthy People initiative recommends to promote partnerships
between communities and other sectors in order to encourage individuals to make informed
health decisions and quantify the efficacy of prevention activities. Healthy People 2020 is the
product of the continuance tradition, after more than 30 years of input from the 4 preceding
Healthy People initiatives, and grounded on previous progresses towards established targets.
Healthy People 2020 includes 42 topics areas with nearly 600 objectives with a recent
inclusion of a new section named “HP2020 & Leading Health Indicators”. The Leading Health
Indicators (LHIs) section focus on high-priority health issues and are organized under 12 topic
areas to assess key points in the health of the nation. The selected health indicators were
designed to address determinants of health, healthy behavior and healthy development across all
age-stages in order to improve health disparities and the overall population health.
There are a series of goals in HP 2020 containing several topics and objectives targeting
the obesity problem and some of them are in alignment with this project. Under the new HP2020
the specific Health Indicator, targeted as a high priority health issue, is related to obesity among
adults who are 20 years and older and it is under the Leading Health Topic “Nutrition, Physical
Activity, and Obesity.” The reasoning for obesity been a high priority issue is the provide
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guidance to overcome high rates of obesity in the U.S.. The Nutrition and Weight Status topic
(NWS) is in alignment with this project. Objective 7 focuses on increasing the proportion of
worksites that offer nutrition or weight management classes or counseling. The NWS objective 8
is to increase the proportion of adults who are at a healthy weight with a 10% target of
improvement. The NWS objective 9 (LHI) is to reduce the proportion of adults who are obese
with a target of 30.5 percent in general and recognizes a gender disparity. The NWS objective 17
is to reduce consumption of calories from solid fats and added sugars in the population aged 3
years and older.
Additional topics in HP2020 that are indirectly aligned and addressed with weight loss
interventions include Heart Disease and Stroke, HDS objective 1 is to increase overall
cardiovascular health in the U.S. population. HDS objective 5 is to reduce the proportion of
adults with hypertension. HDS objective 9 and 10 (under development) are to increase the
proportion of adults with prehypertension and hypertension who met the recommended
guidelines for BMI and physical activity. HDS objectives 13 and 14 are to increase the
proportion of adults with elevated LDL cholesterol who have been advised by a health care
provider regarding cholesterol-lowering management, including lifestyle changes such as
physical activity and weight control. Under the Arthritis topic objective AOCBC-7.1 is to
increase the proportion of overweight and obese adults with doctor-diagnosed arthritis who
receive health care provider counseling for weight reduction. And under the Diabetes topic the
objective D-16 is to increase the prevention behaviors in persons at high risk for diabetes with
prediabetes increasing levels of physical activities, lose weight and reduce the amount of fat or
calories in their diets (Healthy people 2020).
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CHAPTER 2: OBJECTIVE, PURPOSE & JUSTIFIATION OF THE STUDY
2.1 Objective of the Study
The objective of this study was to conduct a secondary data analysis to compare the 2013
AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in adults to the
clinical outcomes obtained in the PLMM intervention implemented among Hispanic adults from
2009 to 2013 in El Paso, Texas. A secondary data analysis was conducted to select the
appropriate sample of participants at baseline and compare their clinical outcomes after the 4month CHW/PS led intervention. The clinical outcomes of weight and BMI loss, WC reduction
and changes in blood pressure reached after the CHW/PS intervention were compared to the
evidence-based recommendations from the 2013 AHA/ACC/TOS Guideline.
2.2 Purpose of the Study
The purpose of the study was to investigate whether the CHW/PS facilitated weight loss
among Hispanic participants in the PLMM intervention that is consistent with the 2013
AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults. The study
aim was to identify participants who achieved weight loss after the completion of the 4-month
PLMM intervention and compare the individual’s clinical outcomes among overweight and
obese participants. In addition, the study explored whether BP changes occurred among those
participants who completed the PLMM intervention. The cases under the secondary data analysis
were those that were identified as needing to lose weight at baseline in the PLMM intervention
based on the 2013 Guideline recommendations. Once overweight and obese participants were
identified, their clinical outcomes after the PLMM intervention were evaluated. The 2013
AHA/ACC/TOS Guideline was used to identify and select participants who were at elevated risk
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for CVD based on the BMI and WC criteria among the participants who enrolled in the PLMM
intervention. According to the 2013 Guideline and based on strong evidence, even a modest
sustained weight loss of 3% to 5% will result in clinically meaningful health benefits for a
patient with CVD risk factors. The clinical health benefits that have an effect on CVD risk
factors with a modest sustained weight loss include reduction in triglycerides, blood glucose,
HbA1C, and reduction of the risk to develop type 2 diabetes. According to the evidence, the
greater the weight loss the greater the benefit; larger weight losses will produce blood pressure
(BP) reduction, LDL and HDL improvement as well as reduction in triglycerides and blood
glucose.
3.3 Justification of the Study
Based on the gaps of evidence that are stated in the 2013 AHA/ACC/TOS Guideline for
the Management of Overweight and Obesity in Adults, research is needed to better understand
and improve the efficiency of on-site lifestyle interventions on key populations including
racial/ethnic groups. Therefore, it is anticipated that this study of the 4-month PLMM
intervention that used guideline recommendations as a reference, will provide insights related to
a lifestyle interventions led by CHW/PS among Hispanics living in the U.S.-Mexico border.
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CHAPTER 3: RESEARCH QUESTIONS, AIMS, AND HYPOTHESIS
3.1 Data Analysis at Baseline:
Following the recommendations in the 2013 AHA/ACC/TOS Guideline for the
management of overweight and obesity the objective was to determine how many participants
who were enrolled in the PLMM intervention met the eligibility criterions.
3.1.1 Research Question 1
What is the proportion of female and male participants in the PLMM intervention that
met the BMI criterion established by the 2013 AHA/ACC/TOS Guideline at baseline?
Specific Aim 1
To identify the proportion of overweight or obese Hispanic adults who were enrolled in
the PLMM intervention using BMI. The selection was done by using the cut-off points of BMI
recommended in the 2013 AHA/ACC/TOS Guideline for the Management of Overweight and
Obesity in Adults. The BMI cut-off points established by the 2013 guideline for male and female
individuals at higher risk are: BMI ≥ 25-29.9 kg/m2 for overweight, and ≥30 kg/m2 for obese.
3.2.1 Research Question 2
What is the proportion of female and male participants in the PLMM intervention that
met the waist circumference criteria as established by the 2013 AHA/ACC/TOS Guideline at
baseline?
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Specific Aim 2
To determine the proportion of Hispanic adults by sex and BMI categories with increased
waist circumference enrolled in the PLMM intervention and categorize them using the current
cut-off points established by the 2013 AHA/ACC/TOS Guideline for the Management of
Overweight and Obesity in Adults. The Panel of the 2013 Guideline recommended by expert
opinion that an increased risk cut-off points for waist circumference are ≥88 cm or ≥35 in for
women and ≥102 cm or ≥40 in for men.

3.2 Data Analysis at Post-Intervention:
After identifying participants at baseline in the PLMM intervention who needed to lose
weight, identify the number of participants who achieved a clinically meaningful health outcome
consistent with the recommendations of the 2013 AHA/ACC/TOS Guideline.
3.2.1 Research Question 3
What is the proportion of female and male participants from the PLMM intervention that
achieved the recommended weight loss of 3%-5% established by the 2013 AHA/ACC/TOS
Guideline at post-intervention?
Specific Aim 3
Among selected participants who completed the 4-month PLMM intervention, determine
the proportion of participants by sex and BMI categories who achieved a reduction in body
weight of 3%-5% established by the 2013 AHA/ACC/TOS Guideline as an outcome that will
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produce clinically health benefits. In addition, determine the percentage of participants who
achieved 10% of body weight.
3.2.2 Research Question 4
What is the proportion of female and male participants that achieved a clinically
meaningful health outcome such SBP or DBP reduction after completion of the 4-month PLMM
intervention?
Specific Aim 4
Among the selected participants who completed the 4-month PLMM intervention,
identify BP changes by sex and BMI categories endorsed by the 2013 AHA/ACC/TOS Guideline
as a dose-response relationship with weight loss achieved by lifestyle intervention. In addition,
identify the proportion of participants that reached the clinically meaningful health reduction of 3
mmHg for SBP or 2 mmHg for DBP.
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3.3 Alternative & Null Hypotheses
Alternative Hypotheses
It is hypothesized that among selected Hispanic adults eligible to lose weight, as
established by the 2013 AHA/ACC/TOS Guideline for the Management of Overweight and
Obesity in Adults, a meaningful health goal of 3% of weight loss after the completion of the 4month PLMM intervention was achieved. A secondary hypothesis is that among the selected
sample of Hispanic adults who completed the PLMM intervention and reached or exceed the
weight loss reduction of 5% will have a clinically meaningful outcome in blood pressure
measurements.
Null Hypothesis
It is hypothesized that among the selected Hispanic adults eligible to lose weight, as
established by the 2013 AHA/ACC/TOS Guideline for the Management of Overweight and
Obesity in Adults, failed to achieve the meaningful health goal of 3% of weight loss after the
completion of the 4-month PLMM intervention. A secondary hypothesis is that among the
selected sample of Hispanic adults who completed the PLMM intervention and reached or
exceed the weight loss reduction of 5% failed to achieve a clinically meaningful outcome in
blood pressure.
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CHAPTER 4: METHODS & MATERIALS
4.1 Overview of the Study
This is a secondary data analysis of the cross-sectional data collected from the PLMM
intervention. A comparison of the recommendations of the 2013 AHA/ACC/TOS Overweight
and Obesity Management in Adults Guideline was made to the clinical outcomes of PLMM
intervention. This study uses the PLMM data to identify overweight and obese Hispanic adults
with a large WC at baseline. This study also uses the data obtained after the 4-months
intervention was completed. Univariate and bivariate analysis were calculated in order to identify
overweight and obese participants as those who met the WC criterion. Variables used in the
study included BMI, gender and age groups: 29 years or less, 30-39 years, 40-49 years, 50-59
years and 60 years and more.
According to 2013 AHA/ACC/TOS Guideline and based on strong evidence, overweight
adults may be at elevated risk for CVD and obese adults may be at elevated risk of mortality
from all causes. After converting the variables of interest (height & weight gathered upon
enrollment) from imperial units to the international unit system, individual BMI were calculated
using the formula: [Weight (kg)/Height2 (m2)]. The BMI cut-off points used in this analysis were
as follow: overweight (25 ≤ 30 kg/m2); obese class I (30≤35 kg/m2); obese class II (35≤40
kg/m2); and obese class III (≥40 kg/m2) (Jensen et al., 2014).
Based on the 2013 guideline, all overweight and obese individuals with one or more risk
factors for increased CVD (diabetes, prediabetes, hypertension, dyslipidemia, and elevated waist
circumference) or other related comorbidities are at high health risk. Elevated WC, if present in
overweight individuals was considered as a risk factor in this study. The original variable for WC
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was converted from inches to centimeters. According to 2013 AHA/ACC/TOS Guideline and
based on expert opinion the cut-off points used for WC were ≥ 88cm (≥35in) for women and ≥
102 cm (≥40in) for men (Jensen et al., 2014). All participants categorized as obese were included
in the secondary data analysis whether or not they met the WC criterion.
The post-intervention data was used to analyze the meaningful health outcomes reached
by all overweight with large WC and obese participants that completed the 4-month intervention
according to the 2013 guideline. To summarize, this secondary data analysis comprises an
assessment of selected participants who completed the PLMM intervention. An evaluation of
their body weight reduction and concomitant changes in their blood pressure (BP) was
performed. Univariate and bivariate analysis were calculated in order to identify the percentages
of weight loss and BP changes in systolic blood pressure (SBP) and/or diastolic blood pressure
(DBP). The results were classified and explored using the variables: BMI classification upon
enrollment, gender and age groups.
According to 2013 AHA/ACC/TOS Guideline and based on strong evidence, selected
participants that reduce 3% or more of their body weight will have a beneficial effect on their
CVD risk factors, and in general morbidity and mortality. The achievement in body weight
reduction was calculated and evaluated; as well as the identification of the number of participants
who reached the goal of 3%, 4% or 5% of weight loss. In addition, larger weight losses such as
10% that could produce greater benefits were also explored (Jensen et al., 2014).
According to 2013 AHA/ACC/TOS Guideline and based on strong evidence a weight
loss of 5% or greater is likely to result in BP reduction (Jensen et al., 2014). Therefore, among
the selected participants that completed the 4-month PLMM intervention, changes in BP,
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specifically mean SBP, and mean DBP were analyzed. In addition, the number of participants
that reached the clinically significant reduction of 3 mmHg for SBP and 2 mmHg DBP were
explored.
4.1.1 Promotora-Led Mi Corazón Mi Comunidad Intervention
The PLMM Intervention was part of the Health Education and Assessment Research
Team (HEART) project, a community-based participatory research (CBPR) funded by the
National Institutes of Health/National Institute on Minority Health and Health Disparities
(Balcázar et al., 2012). The goal of the PLMM intervention was to reduce risk factors for CVD in
residents living in two low-income areas (zip codes 79907 and 79915) in El Paso, Texas. These
two zip codes were chosen due to its high number of Mexican-American residents with lower
access to health care as compared to the city’s average. Community Health Workers (CHW) or
Promotores de Salud (PS) trained by the designers of the PLMM study facilitated the
intervention.
The 16-week PLMM intervention enrolled 753 participants in five cohorts and 411
completed the program. The PLMM intervention incorporated practice methods identified by the
CDC Task force on Community Preventive Services. Stakeholders including three academic
institutions, a health care center, city parks and recreation supported the intervention. The
PLMM intervention’s objective was to promote participants’ healthy behaviors by providing
resources such as heart-health education, physical activity, and nutrition education (Balcázar et
al., 2012). The CHW/PS provided the heart-health education through the “Mi Corazon Mi Vida”
Promotor curriculum developed by NHLBI for Mexican-American populations to encourage
healthy behaviors.
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The 4-month intervention organized physical activities that were provided for the
duration of the study. These included walking sessions in the park and in-door classes such as
swimming and aerobics. In addition, PS provided participants with nutrition education, cooking
demonstrations, and grocery store tours (de Heer et al., 2015).
4.2 Theoretical Framework
The Transtheoretical Model (TTM) (Prochaska, Redding & Ever, 2002) provides the
framework to modify or change harmful behaviors. As stated in this behavioral model, change
occurs in stages over time and individuals go through many decision processes “little decisions”
that finally will take part of the desired behavioral change. The TTM and its six stages has been
useful as theoretical framework in weigh management as outlined by other researches (Johnson
et al., 2008 & Rossi et al., 1994 & Seals, 2007). The Stages of Change are constructed for six
progression levels (pre-contemplation, contemplation, preparation, action, maintenance, and
termination) where the individual move at their own pace towards the behavioral change (Figure
2). To move from one stage to another in the TTM the individual will have to engage in several
processes, key constructs in this theory are self-efficacy and decisional balance. Self-efficacy is
the person’s belief that he or she can change a specific behavior and this should increase as the
individual progress through the stages. Decisional balance is the process of weighing the pros
and cons that will determine decision-making to move or not toward change. The individuals
may enter in this loop of progression at any stage, meaning that they might not start at all the first
level of the TTM.
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Figure 2. Spiral model of the stages of change in the Transtheoretical Model (Prochaska &
DiClemente, 1992).
Treatment of overweight and obesity requires a multidisciplinary approach that includes
diet changes, physical activity plan and behavioral therapy, as well as readiness assessment to
make lifestyle changes to achieve weight loss. Once the individual’s readiness to make a lifestyle
change is determined, appropriate intervention and counseling can be directed to the individual
to make the commitment more efficient. The majority of overweight and obese patients usually
are in the preparation, action or maintenance stages and awareness of their health risk positions
these patients into the advance stages of readiness to lose weight, improve diet and/or to increase
physical activity (Wee, Davis & Phillips, 2005).
The 2013 AHA/ACC/TOS Guideline developed for the management of overweight and
obesity in adults are supported for the TTM and by expert opinion the panel advises to assess the
readiness of the patient to make lifestyle changes in order to achieve weight loss (Jensen et al.,
2014). Regardless of the participant’s weight or stage of readiness for change, either prevention
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or loss weight counseling should occur among high-risk populations. According to Wee, Davis
& Phillips findings (2005), the awareness of the health risk due to overweight and obese should
be advice from physician to patients and provide counseling about weight loss and lifestyle
changes. The idea of overweight or obesity prevention, detection and treatment cannot rely only
on primary care providers at one patient at a time. CHW or PS could play an important role as
the first front in the battle against obesity, through community education, early detection,
appropriate counseling and prompt resources connection and treatment.
4.3 Population
The study was conducted in the city of El Paso located at the far west of Texas directly
on the border region of the U.S. and Mexico. The U.S. metropolitan area covers all El Paso and
Hudspeth counties with an estimated population of 833, 487 in 2014 (U.S. Census Bureau,
2014). El Paso, Texas is mostly a Mexican-American community with approximately 81.2% of
its population being from Hispanic or Latino origin (versus the national average 17.4%).
According to the U.S. Census Bureau (2014), the age distribution of the population was
equivalent to state and national averages: female population 51% (U.S. avg. 50.8%), persons
under 18 years 28.3 % (U.S. avg. 23.1%), and persons under 5 years 8.1% (U.S. avg. 6.2%).
However, the estimated population living below the poverty level was 23.3% in El Paso; higher
than average in Texas (17.6%) and in U.S. (15.4%). Also the residents who spoke at home other
language than English were 73% (U.S. avg. 20.7%) and foreign-born occupants were 26% (U.S.
avg. 12.9%). Furthermore, the median household income reported in El Paso was around
$40,157; whereas in Texas and U.S. was higher ($ 51,900 and $53,046 respectively) and the
residents without insurance was 28.4% above the national average (10.4% in 2014) higher. The
educational attainments were lower than the state and national averages; people aged 25 years or
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more 74% (vs. 81.2% and 86.0%) had at least a high school degree and 20.7% (vs. 26.7% and
28.8%) a bachelor’s degree or higher (U.S. Census Bureau, 2014).
4.4 Sample Size
The PLMM intervention aimed at the reduction of CVD risks factors among residents of
El Paso, Texas. The eligibility criteria for this secondary data analysis was 18 years or older and
availability of clinical measurements (Height & Weight &Waist Circumference) obtained at
baseline. The exclusion criteria was lack of identification as Hispanic (either by selfidentification as Hispanic, Spanish as language of preference and/or place of birth in Mexico).
For the purpose of this secondary data analysis, a convenience sample of 705 participants
resulted from total initial enrollment of 753 in the PLMM intervention.
4.5 Recruitment and Selection
Promotores de Salud or CHW recruited participants at various community health fairs
and recreation centers and by means of personal contacts and referrals, in addition to radio and
television Spanish broadcasts (Balcázar et al., 2012).
The inclusion criteria for the PLMM participants were adults, capable to participate in
physical activities, and residents in the 2 selected zip codes (79907 & 79915) with the intention
of remain at the same residence for the next 10 months (Balcazar et al., 2010). The exclusion
criteria were being or planning on becoming pregnant within the next 6 months, intentions to
move out from the zip codes area in the next 6 months, were current members of the YWCA,
restriction of participating in any type of physical activity by a doctor, medical history of severe
heart condition and if participants suffered any injure in the previous 6 month of the study.
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4.6 IRB Approval & Ethics
This secondary data analysis uses information from the PLMM database. Access to
personal identification information from participants has been protected and coded. Therefore,
the current study is exempt from IRB evaluation according to the U.S. Department of Health &
Human Services regulation 45 CFR 46. 101 (b)(4). The electronic databases are kept on original
flash-drives locked in a file cabinet inside the P.I.'s office and their use is only on passwordprotected computers.
The Institutional Review Board granted approval for the secondary data analysis of the
PLMM intervention (IRB number: 86134-20).
4.7 Data Collection Instruments
Participants completed a questionnaire at enrollment and after 16-week when the
intervention was completed. The questionnaires were completed in either English or Spanish.
Information gathering included demographic information, educational and socio-economic
status, acculturation, food frequency consumption, and intentions to engage in healthy eating
(Balcázar et al., 2012). Trained research staff following standard procedures collected clinical
data at baseline and 4 months; the clinical measurements assessed included height, weight, waist
and hip circumference, and systolic/diastolic blood pressure. For the purposes of this secondary
data analysis, the following variables were used: demographic and clinical measurements.
4.7.1 Demographics
Demographic information obtained from the selected sample of participants for the
purpose of this study included: sex, age, marital status, time living in the U.S.A., annual
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household income, health insurance, ethnicity, place of birth, language of preference, years of
education, and employment.
4.7.2 Clinical Measurements
The participants’ measurements obtained at baseline and at 4-month were available from
the original database and converted from imperial units to the international unit system. The
variables of interest for this secondary data analysis were the following: height, waist
circumference (WC), weight, mean SBP and mean DBP. BMI was calculated using the formula
(weight [kg] / height2 [m2]).
4.8 Statistical Analysis Plan
Data was selected to create a new SPSS database for the purpose of this study. The
database included Hispanic adult participants only; excluding those with a different ethnicity.
The IBM SPSS statistic software (SPSS-version 22) was used for statistical analysis. Both
graphical displays and numerical measures were used to explore and summarize the data:
frequencies and/or percentages were computed for categorical variables and central tendency and
variability measures were obtained for each continuous variable.
Gender and BMI category comparison were made via either paired t tests or chi-square
tests. Linear regression models were performed to evaluate the correlation between the
participant’s demographics (e.g. education, income, age, gender etc.) and weight loss reduction,
as well as changes in SBP and DBP.
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CHAPTER 5: RESULTS
5.1 Descriptive Statistics of the Selected Participants
The PLMM intervention implemented at the U.S. – Mexico border promoted healthy
behaviors among participants by providing heart-healthy education including nutrition education
classes and physical activities. Initially, the PLMM intervention enrolled 753 participants from
2009 to 2013. From the original sample, 48 participants were excluded for the following reasons:
2 participants did not meet the age requirement, 45 participants were not identified as Hispanics
and the WC measurement of 1 participant was not available. After conducting a screening for the
inclusion and exclusion criteria for this secondary data analysis, 705 Hispanic participants were
included in the analysis with the purpose of assessing the effectiveness of the PLMM
intervention in comparison to the 2013 AHA/ACC/TOS Guideline for the Management of
Overweight and Obese in Adults. At baseline, 500 participants were eligible to lose weight
according to criterions in the 2013 AHA/ACC/TOS Guideline, 285 participants from the selected
sample completed the 4-month intervention and were assessed for the effectiveness of the
PLMM intervention.
The demographic characteristics of the PLMM selected sample of participants for the
purpose of this secondary data analysis are shown in Table 4. The average age of the eligible
Hispanic participants at baseline was 46.3 (SD± 12.60) years with more than three-fourths of the
sample being females (86.2%). After the PLMM intervention, only 57% of the participants were
retained and their mean age was 48.2 (SD±12.2) years while the proportion by gender was 89.8%
females and 10.2% males. At baseline, the majority of participants selected Spanish as their
language of preference (84.4%) and nearly two-thirds were born in Mexico (64.3%). The
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majority of eligible Hispanic adults reported an average of 11.85 (SD± 3.7) years of education
completed at baseline and only one-third of participants achieved or continued their education
after high school; furthermore, 62.1% of the participants selected Mexico as the main place
where they obtained their education.
Upon enrollment in the PLMM intervention, more than three-fourths (76.46%) of
participants reported living in the U.S. for more than 10 years; the average living time in the
U.S. of the eligible participants was 28.77 years (SD± 17.39), two more years than the original
sample. Among the PLMM participants selected for the purpose of this study, 71.4% reported
having an annual income below US $20,000. About 60% of the selected sample of participants
reported being unemployed at enrollment and the main selected reason (48.24%) was “taking
care of house or family.” Among two-fifths of participants that reported being employed, 59.21%
were employees of private companies or working for wages. The results also show that almost
half of participants (47.6%) did not have any form of medical insurance. The marital status of
55.7% of participants was married or living with a partner. Half of the selected sample of
Hispanic adults reported being house owners or being in the process of buying a house.
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Table 4. Demographic Characteristics of the Selected Sample of Hispanic Adult Participants
from the PLMM Intervention upon Enrollment.
PLMMI
(N=705)
Mean±SD or
n (%)
44.7±13.19

Baseline
(n=500)
Mean±SD or
n (%)
46.3±12.60

Post-Intervention
(n=285)
Mean±SD or
n (%)
48.2±12.21

111 (15.7)
594 (84.3)

69 (13.8)
431 (86.2)

29 (10.2)
256 (89.8)

607 (86.1)
98 (13.9)

422 (84.4)
78 (15.6)

245 (86.0)
40 (14.0)

459 (65.1)
242 (34.3)
3 (0.4)
11.93±3.67

321 (64.3)
176 (35.3)
2 (0.4)
11.85±3.72

187 (65.8)
95 (33.5)
2 (0.7)
11.79±3.56

429 (60.9)
263 (37.3)
4 (0.6)
26.77±17.67
162 (23.0)
134 (19.0)
129 (18.3)
263 (37.3)

308 (62.1)
186 (37.5)
2 (0.4)
28.77±17.39
93 (19.2)
82 (16.9)
102 (21.0)
208 (42.9)

181 (64.0)
100 (35.3)
2 (0.7)
29.88±17.86
53 (19.1)
41 (14.8)
54 (19.5)
129 (46.6)

Marital Status
Never married
Married or in Couple as marriage
Divorced, Separated or Widowed

118 (16.7)
393 (55.7)
191 (27.1)

75 (15.0)
278 (55.7)
146 (29.3)

31 (10.9)
172 (60.6)
81 (28.5)

Household Income
Less than 10k
10k to 20k
More than 20k

250 (35.5)
249 (35.3)
200 (28.4)

177 (35.7)
177 (35.7)
142 (28.6)

92 (32.4)
104 (36.6)
88 (31.0)

Employed
No
Yes, full time
Yes, part time

430 (61.0)
163 (23.1)
109 (15.5)

307 (61.5)
114 (22.8)
78 (15.6)

183 (64.4)
55 (19.4)
46 (16.2)

342 (48.5)
142 (20.1)
97 (13.8)
120 (17.0)

236 (47.6)
100 (20.2)
72 (14.5)
88 (17.7)

121 (42.9)
60 (21.3)
48 (17.0)
53 (18.8)

Variable

Age, years
Gender
Male
Female
Language of Preference
Spanish
English
Place of Birth
Mexico
United States
Other (Puerto Rico)
Years of Education
Place of Education
Mexico
United States
Other
Time Living in the US
Less than 10 years
10-20 years
20-30 years
More than 30 years

Health Insurance
No Insurance
Private Insurance
Medicare or Medicaid
Other
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5.2 Specific Aim 1: Identification of Overweight and Obese Participants at Baseline
Specific aim 1 was to identify and select a sample of Hispanic adults enrolled in the
PLMM intervention who had a BMI within the following categories: overweight (25 ≤ 30
kg/m2), obese class I (30≤35 kg/m2), obese class II (35≤40 kg/m2) and obese class III (≥40
kg/m2).
A Univariate Analysis was conducted in order to identify the proportions of overweight
and obese participants as a criterion of eligibility. Among the 705 Hispanic adult participants
who met the inclusion criteria from the PLMM intervention, a total of 85.1% of participants
(600) had a BMI corresponding to overweight or obese (class I, II and III) and consistent with
the 2013 AHA/ACC/TOS Guideline (Table 5).

Table 5. Percentages of BMI categories from selected Hispanic Adults at baseline.

BMI
by Category
Underweight

PLMM
Participants
(N=705)
N (%)
3 (0.4)

≤18.5

Selected
Participants
% (n)
(n=600)
-

2013 Guideline
Cut points

Normal Weight

102 (14.5)

18.5 ≤ 24.9kg/m2

-

Overweight

218 (30.9)

25 ≤ 30 kg/m2

218 (36.3)

Obesity class I

209 (29.6)

30≤35 kg/m2

209 (34.8)

Obesity class II

99 (14.0)

35≤40 kg/m2

99 (16.5)

Obesity class III

74 (10.5)

≥40 kg/m2

74 (12.3)

A total of 3 participants were underweight and 102 were normal weight; therefore,
14.9% of the PLMM participants were excluded from further analysis.
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Among the 600 participants selected at baseline, 83.7% (502) were female and 16.3%
(98) were males. The majority of participants belong to the overweight category with 36.3%
(218) participants, followed by 34.8% (209) participants in obesity class I. 16.5% (99) were from
obesity class II and 12.3% (74) were in obesity class III. At baseline, almost two thirds of
participants were categorized as obese (63.7%) while the rest of the group was classified as
overweight (36.3%). Among the BMI categories selected for this secondary data analysis at
baseline (overweight and obesity class I, II and III) the distribution within gender is shown in
Table 6. The majority of the females belong to the overweight category 36.7% (182) while
among the males the majority belong to the obese class I category 42.9%.

Table 6. Hispanic Adult Selected Participants based on the BMI criteria by gender.
n (%)

Overweight

Obese Class I

Obese Class II

Obese Class III

Female 502 (83.7)

182 (36.7)

167 (33.1)

82 (16.7)

71 (13.9)

Male

98 (16.3)

36 (36.3)

42 (42.9)

17 (17.3)

3 (3.1)

Total

(n=600)

218 (36.3)

209 (34.7)

99 (16.8)

74 (12.2)

The selected sample of Hispanic adults that met BMI criterion from the PLMM
intervention at baseline had a mean BMI of 32.75 kg/m2 (SD±5.72). The average BMI among
female was 32.91 kg/m2 (SD±5.91) and 31.92 kg/m2 (SD±4.55) among male (Figure 3) with no
statistical significance differences in t-test (p=0.118).
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Figure 3. Mean BMI by gender groups among overweight and obese Hispanic adults
selected at baseline from the PLMM intervention.

5.3 Specific Aim 2: Identification of Waist Circumference as Risk Factor at Baseline
Specific aim 2 was to identify the WC risk factor (women ≥ 88cm and men ≥ 102 cm)
among the selected sample of Hispanic adults upon enrollment in the PLMM intervention and
that were also categorized as being overweight or obese. Based on the 2013 Guideline
recommendations all participants that were categorized as obese were included in further
analysis whether they met or not the WC criterion.
Univariate Analysis were conducted in order to identify overweight and obese
participants that met the WC criterion. Among the 600 selected Hispanic adult participants who
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were that classified as overweight and obese, a total 80.2% of participants (481) met the WC risk
factor (Figure 4).

Figure 4. Selected sample of Hispanic adult participants from the PLMM intervention that met
the WC risk factor at baseline.

The WC risk factor was absent in 19.8 % the sample of selected participants. Almost
3.2% of those participants that did not met the WC risk factor criterion were obese at baseline;
17 of them belonged to the obese class I category and 2 participants in the obesity class II
category (Table 7). Among the selected overweight participants (218) more than half (54.1%)
met the WC criterion at baseline shown in Figure 5.
A 16.7% of participants were classified as overweight with no WC as a risk factor;
therefore, a total of 100 participants were excluded from further analysis (Figure 5).
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Figure 5. Selected sample of Hispanic adult participants from the PLMM intervention
that met the WC risk factor at baseline by BMI categories.

Table 7. Percentages of WC categories of Selected Hispanic adults at baseline.
BMI Categories

at Enrollment

PLMM Participants

Selected

(N=600)

Participants

No Risk Factor

Risk Factor

(n=500)

n (%)

n (%)

n (%)

100 (45.9)

118 (54.1)

118 (23.6)

Obesity Class I

17 (8.1)

192 (91.9)

209 (41.8)

Obesity Class II

2 (2)

97 (98)

99 (19.8)

Obesity Class III

-

74 (100)

74 (14.8)

119 (19.8)

481 (80.2)

500 (83.3)

Overweight

Total
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Based on the 2013 AHA/ACC/TOS Guideline a total of 83.3% (500) of Hispanic Adult
participants from the PLMM intervention were eligible for weight loss treatment at baseline. The
distribution by BMI categories at enrollment is shown in table 7. The selected sample included
118 overweight participants with the WC as risk factor and all 382 obese participants.

Table 8. Hispanic Adult Selected Participants based on the WC criteria by gender.
n (%)
Male

69 (13.8)

Overweight

Obese Class I

Obese Class II

Obese Class III

7 (10.1)

42 (60.9)

17 (24.6)

3 (4.3)

Female 431 (84.2)

111 (25.8)

167 (38.7)

82 (19.0)

71 (16.5)

Total

118 (23.6)

209 (41.8)

99 (19.8)

74 (14.8)

(n=500)

The distribution of WC as risk factor by gender was as follows. Among 69 selected males
at baseline, 60 had a WC risk factor (≥102cm) and 9 males that belonged into the obese
classification did not. Among 431 selected females at baseline, 421 had a WC risk (≥88cm) and
10 women that belonged into the obese classification did not met this criterion. The distribution
of the selected participants (n=500) by BMI who met the WC criterion (Table 8) shows that the
majority of the selected participants (41.8%) belong into the obese class I category; the
distribution by gender shows similar results.
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Figure 6. Mean WC by gender among Hispanic adults classified as overweight with WC
as risk factor and obese selected from the PLMM intervention at baseline.

Overall the mean WC for all selected participants at baseline (n=500) was 104.26 cm
(SD± 11.76); the mean WC was 109.82cm (SD±9.92) among males and 103.37cm (SD±11.80)
among females (Figure 6).
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5.4 Specific Aim 3: Identification of Weight Loss Post-Intervention
Specific aim 3 was to determine the achievements of the selected participants after the
completion of the 4-month PLMM intervention. Among overweight individuals with WC as risk
factor and all obese individuals (n=500) that were selected at baseline for this secondary data
analysis fifty-seven percent (285) were retained after the 4-month PLMM intervention and
completed the follow up assessment. The distribution of the selected participants by gender and
by BMI categories are shown in Table 9.

Table 9. Hispanic Adult Selected Participants that Completed the PLMM intervention.
n (%)

Overweight
(n=68)

Obesity
Class I
(n=113)

Obesity
Class II
(n=60)

Obesity
Class III
(n=44)

TOTAL
(n=285)

Males

4 (13.8)

4 (13.8)

8 (27.6)

2 (6.9)

29 (10.2)

Females

64 (25.0)

64 (25.0)

52 (20.3)

42 (16.4)

256 (89.8)

TOTAL

68 (23.9)

113 (39.6)

60 (21.1)

44 (15.4)

285 (100)

Among the 285 retained participants, only two-thirds (68.07%) lost weight and 91
(31.93%) individuals gained weight or did not lose any. Among the selected overweight with
WC as risk factor and obese participants that were retained after the PLMM intervention, the
mean weight at enrollment was 87.11 kg (SD±15.60) and the mean weight after the PLMM
intervention was 85.80 kg (SD±15.67). The mean weigh loss among the 285 retained participants
after the PLMM intervention was 1.31kg (SD±3.33) and with Pair T-Test (p=0.001) a
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statistically significant difference was found (Figure 7). The mean BMI at enrollment among the
selected sample was 34.01kg/m2 (SD±5.30) and after the PLMM intervention was 33.50 kg/m2
(SD±5.37). The mean BMI difference after the PLMM intervention was 0.51 kg/m2 (SD±1.29)
and with Pair T-Test (p=0.001) a statistically significant difference was found (Figure 8). The
mean WC at enrollment was 104.09 cm (SD±11.02) and after the PLMM intervention was
100.76 cm (SD±12.28). The mean WC difference after the PLMM intervention was 3.32 cm
(SD±6.38) and with Pair T-Test (p=0.001) a statistically significant difference was found; all
three measurements were within a CI 95% (Figure 9).

Figure 7. Mean weight among the selected sample of Hispanic adults at baseline and after the
PLMM intrevention.
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Figure 8. Mean BMI among the selected sample of Hispanic adults at baseline and after the
PLMM intrevention.

Figure 9. Mean WC among the selected sample of Hispanic adults at baseline and after the
PLMM intrevention.
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Moreover, the percentage of body weight loss by the selected 285 participants that
completed the PLMM intervention in 4-months was 1.48% (SD±3.77). The percentage of body
weight loss by BMI categories at enrollment were noticeably greater among those classified as
obesity class II with 1.90% (SD±4.34) followed by obesity class I with 1.59% (SD±4.07),
obesity class III 1.22% (SD±2.98) and overweight 1.11% (SD±3.22). No statistically significant
difference with ANNOVA test (p=0.639) was found among groups (Figure 10).

Figure 10. Mean of percent of body weight lost among the selected sample of Hispanic adults
after the PLMM intrevention by BMI categories.
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The mean weight lost was 1.72kg (SD±2.65) among males and 1.26kg (SD±3.40) among
females (Figure 11). Moreover, the percent body weight lost by males was greater 1.81%
(SD±2.63) than the percent of 1.44% (SD±3.90) reached among females (Figure 12). No
statistically significant difference was found by gender.

Figure 11. Mean weight loss among the selected sample of Hispanic adults after the PLMM
intrevention by gender.
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Figure 12. Mean of percent of body weight lost among the selected sample of Hispanic adults
after the PLMM intrevention by gender.

The comparison of the changes reached by the selected sample of participants that
completed the 4-months PLMM intervention and met the BMI and WC criteria according to the
2013 AHA/ACC/TOS Guideline are shown in Table 10. The clinical measurements of weight,
BMI, and WC of the 285 selected participants at baseline, post-intervention and differences were
stratified by BMI categories. The obese class II category reached the highest weight loss with
1.77 kg (SD±3.27) followed by the obese class I and obese class II groups with 1.35 kg
(SD±3.49) and 1.33 kg (SD±3.35) respectively. Accordingly, the obese grade II category had the
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greatest BMI reduction with 0.70 kg/m2 (SD±1.57) and the greatest WC reduction with 3.67 cm
(SD±5.74). Interestingly, the overweight group reached the lowest achievements for weight loss
with 0.82 kg (SD±2.30) and a BMI reduction of 0.31 kg/m2 (SD±0.89) but not for WC with a
3.12 cm (SD±9.29) decrease. The obese class III category reached the lowest reduction in WC
with 2.62 cm (SD±4.73). No statistically significant difference was found with ANOVA test at
p=0.05 between groups.
Among the selected 285 participants based on the 2013 AHA/ACC/TOS Guideline that
completed the 4-months PLMM intervention, a total of 28.1% (80) participants achieved the goal
of a 3% weight loss or more. A 4% weight loss goal was reached by 17.2% (49), the 5% goal
was achieved by 11.9% (34) and only 2.5% (7) participants achieved the 10% weight loss goal.
The table 11 contains the proportion of participants that achieved the weight goal stratified by
gender and BMI categories. The obese class I group has the highest proportion (31%) between
groups that reached the 3% weight loss. The mean weight loss was explored among the
participants that achieved the weight loss goals. Among participants that achieved a 3%, 4%, 5%
and 10% goals the mean weight loss was 5.06kg (SD±3.14), 6.4 kg (SD±3.35), 7.46 (SD±3.52)
and 13.19kg (SD±3.27) respectively.
Linear regression models were performed (data not shown) to evaluate the correlation
between weight loss reduction and the participant’s demographics using the variables of gender,
age upon enrollment, education and annual income. However, no statistically significant
difference was found.
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Table 10. Changes in clinical measurements of selected participants that completed the 4-month PLMM intervention by BMI
categories (mean±SD).

Weight (kg)
Baseline
4-months
Diff (B-4)
BMI (kg/m2)
Baseline
4-months
Diff (B-4)
WC (cm)
Baseline
4-months
Diff (B-4)
SBP (mmHg)
Baseline
4-months
Diff (B-4)
DBP (mmHg)
Baseline
4-months
Diff (B-4)

Overweight
(n=68)

Obese Class I
(n=113)

Obese Class II
(n=60)

Obese Class III
(n=44)

TOTAL (n=285)

p-value

71.34±6.99
70.51±6.92
0.82±2.30*

83.83±9.20
82.48±9.51
1.35±3.49*

95.08±8.79
93.31±9.87
1.77±3.97*

109.03±14.25
107.70±14.52
1.33±3.35*

87.11±15.60
85.80±15.67
1.31±3.33

<0.001

28.02±1.35
27.71±1.54
0.31±0.89*

32.38±1.40
31.87±1.88
0.51±1.32*

37.01±1.28
36.30±1.94
0.70±1.57*

43.37±3.13
42.85±3.50
0.52±1.31*

34.01±5.30
33.50±5.37
0.51±1.29

<0.001

94.73±5.15
91.60±10.07
3.12±9.29*

100.91±6.85
97.39±7.65
3.52±5.03*

109.12±8.13
105.45±8.26
3.67±5.74*

119.82±9.72
117.18±11.07
2.62±4.73*

104.09±11.02
100.76±12.28
3.32±6.38

<0.001

125.97±17.56
125.68±18.43
0.28±14.51

128.74±17.35
128.66±14.68
0.07±12.26

131.35±17.42
132.32±15.62
-0.97±11.46

136.04±21.40
129.87±14.99
6.17±14.67*+

129.75±18.28
128.91±15.97
0.84±13.20

0.280

75.64±8.56
74.55±9.01
1.08±7.36

77.41±9.33
77.00±8.77
0.41±6.68

76.86±9.28
77.45±8.48
-0.58±7.98

77.22±9.16
76.62±9.02
0.59±7.23

0.164

* The mean difference is significantly different at the 0.05 level
+ The reported p-value=0.008
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79.65±9.21
77.70±10.15
1.94±7.30

Table 11. Achievement of weight loss goal among the selected participants that completed the 4-month PLMM intervention by
BMI categories (n, %).
Weight Loss
Goal 3%
Male
Female
Goal 4%
Male
Female
Goal 5%
Male
Female
Goal 10%
Male
Female

Overweight
(n=68)
18 (26.5)
2 (50.0)
16 (25.0)
10 (14.7)
1 (25.0)
9 (14.1)
6 (8.8)
1 (25.0)
5 (7.8)
1 (1.5)
1 (1.6)

Obesity Class I
(n=113)
35 (31.0)
5 (33.3)
30 (30.6)
21 (18.6)
4 (26.7)
17 (17.3)
15 (13.3)
3 (20.0)
12 (12.2)
3 (2.7)
3 (3.1)

Obesity Class II
(n=60)
16 (26.7)
2 (25.0)
14 (26.9)
12 (20.0)
2 (25.0)
10 (19.2)
9 (15.0)
9 (17.3)
2 (3.3)
2 (3.8)
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Obesity Class III
(n=44)
11 (25.0)
11 (26.2)
6 (13.6)
6 (14.3)
4 (9.1)
4 (9.5)
1 (2.3)
1 (2.4)

TOTAL
(n=285)
80 (28.1)
9 (31.0)
71 (27.7)
49 (17.2)
7 (24.1)
42 (16.4)
34 (11.9)
4 (13.8)
30 (11.7)
7 (2.5)
7 (2.5)

5.5 Specific Aim 4: Identification of Blood Pressure Changes Post-Intervention
Specific aim 4 was to identify blood pressure changes among the selected Hispanic adults
who were selected according to the 2013AHA/ACC/TOS Guidelines at baseline and completed
the 4-months follow up of the PLMM intervention. Among the overweight individuals with WC
as risk factor and obese individuals that were selected at baseline from the PLMM intervention
for further analysis (n=500), as mentioned before, 285 (57.0%) were retained and completed the
4-month follow up.
Regarding SBP, almost half of the individuals (49.1%) had a reduction in blood pressure.
On the other hand, 145 individuals did not had a reduction or presented an increase in SBP. In
the case of DBP, more than half of the selected participants (55.4%) had a reduction and 127
individuals had an increase in DBP or did not had a reduction. Among the 285 retained
participants, the mean systolic blood pressure at enrollment was 129.97 mmHg (SD±18.28) and
after the PLMM intervention was 128.91 mmHg (SD±15.97). The reduction in SBP was 0.84
mmHg (SD±13.20) and there was no statistically significant difference with paired t-Test
(p=0.280) (Figure 13). The mean DBP at enrollment was 77.22 mmHg (SD±9.16) and after the
PLMM intervention was 76.62 mmHg (SD±9.02). The reduction in DBP was 0.59 mmHg
(SD±7.23) and there was no statistically significant difference with paired t-Test (p=0.164)
(Figure 14).
However, the reduction in SBP by the selected sample of 285 participants by BMI
categories at enrollment were significantly greater among those classified as obesity class III
(Table 9) with a reduction of 6.17mmHg (SD±14.67).
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Figure 13. Mean SBP among the selected sample of Hispanic adults at baseline and after the
PLMM intrevention.

Figure 14. Mean DBP among the selected sample of Hispanic adults at baseline and after the
PLMM intrevention.
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The SBP reduction in the overweight category was 0.28 mmHg (SD±14.51) while the
obesity class I group had a 0.07 mmHg (SD±12.26) reduction. The obesity class II group
reported a mean reduction of -0.97 mmHg (SD±11.46) (Figure 15). The ANNOVA test shows
statistically significant difference (p=0.031) between the reduction reached among BMI groups.
The post hoc Bonferroni test shows that the reduction reached by the obesity class III group after
the PLMM intervention was statistically significant difference when compared to obesity class II
(p=0.037) and nearly significant when compared to Obesity class I (p=0.054); however, no
difference was found with the overweight category (p= 0.124).

Figure 15. Mean SBP among the selected sample of Hispanic adults after the PLMM
intrevention by BMI categories.
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The reduction in DBP by the selected 285 participants by BMI categories at enrollment
were visibly greater among those classified as obesity class III with a reduction of 1.94 mmHg
(SD±7.307). The reduction in DBP among the overweight category was 1.08 mmHg (SD±7.36)
and for class I obesity 0.41 mmHg (SD±6.68). The obesity class II category report a negative
mean of -0.58 mmHg (SD±7.98). The ANNOVA test did not shows statistically significant
difference between the reductions reached on DBP among BMI categories (Figure 16).

Figure 16. Mean DBP among the selected sample of Hispanic adults after the PLMM
intrevention by BMI categories.
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The reduction in BP by gender was explored and these results are shown in Figures 17 &
18. Among the selected 29 males, the mean reduction in SBP was 0.51mmHg (SD±14.09) while
the mean reduction in DBP was 0.29 mmHg (SD±8.65). Among the selected 256 females, the
mean reduction in SBP was 0.88mmHg (SD±13.12) and mean reduction in DBP was 0.63mmHg
(SD±7.08). There was no significant difference between mean ranks for females (143.84) and
males (135.55) with Mann-Whitney test for SBP (p=0.608); nor either for DBP (p=0.992)
between females (mean rank= 143.02) and males (mean rank= 142.86).

Figure 17. Reduction in SBP among the selected sample of Hispanic adults after the PLMM
intrevention by gender categories.
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Figure 18. Reduction in DBP among the selected sample of Hispanic adults after the PLMM
intrevention by gender categories.

Among the 285 selected participants based on the 2013 AHA/ACC/TOS Guideline that
completed the PLMM intervention, a total of 42.1% (120) participants had a clinically significant
reduction of 3 mmHg on SBP (Table 12). The clinically significant reduction of 2 mmHg on
DBP was reached by 45.3 % (129) participants. The majority of participants belonging to the
obesity class II had clinically significant reduction in SBP and DBP (Table 10). No statistically
significant difference was found between BMI groups with Pearson Chi-Square test at p-value
0.05. Linear regression models were performed (data not shown) to evaluate the correlation
between changes in SBP and DBP and the participant’s demographic information using the
variables of gender, age upon enrollment, education and annual income. However, no
statistically significant difference was found.
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Table 12. Clinically significant blood pressure reduction achievement after the 4-month PLMM intervention by BMI
categories 3 mmHg reduction in SBP and 2 mmHg reduction in DBP (n, %).
Blood Pressure

Overweight

Obesity Class I

Obesity Class II

Obesity Class III

TOTAL

(n=68)

(n=113)

(n=60)

(n=44)

(n=285)

30 (44.1)

44 (38.9)

22 (36.7)

24 (54.5)

120 (42.1)

Males

4 (100)

3 (20.0)

1 (50.0)

1 (50.0)

9 (31.0)

Females

26 (40.6)

41 (40.6)

21 (40.4)

23 (54.8)

111 (43.4)

32 (47.1)

59 (52.2)

19 (31.7)

24 (54.5)

129 (45.3)

Males

3 (75.0)

9 (60.0)

1 (12.5)

1 (50.0)

14 (48.3)

Females

29 (45.3)

45 (45.9)

18 (34.6)

23 (54.8)

115 (44.9)

SBP ≥3mmHg

DBP ≥2mmHg
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CHAPTER 6: DISCUSSION
The 2013 AHA/ACC/TOS Guideline is based on strong scientific evidence and serves as
a reference for health providers to overcome obesity and its related chronic diseases. By using
the 2013 AHA/ACC/TOS Guideline to select the data from Hispanic obese and overweight with
large WC as risk factor from the PLMM participants, the intervention showed much better
results than programs that only use regular weight loss information sessions with their patients.
Wadden and colleagues reported a decrease of 0.7% of body weight in patients who were
followed for one year and participated in weight loss information sessions, however this program
did not include behavioral strategies (Wadden et al., 2009); while the current study showed that a
lifestyle intervention led by CHW/PS resulted in 1.48 % weight loss in a 4-month period.

The 2013 AHA/ACC/TOS Guideline reported the need to understand and improve the
efficiency of on-site lifestyle interventions on key populations including racial/ethnic groups.
The results from this study show that the recommendations provided by the 2013
AHA/ACC/TOS Guideline are valid for Hispanics living in the U.S. Mexico border region. The
results showed that from the selected sample of Hispanic participants that completed (n=285) the
PLMM intervention 68% participants lost weight. Similar results were found by the Look
AHEAD intervention study, in where a population with diabetes that included minorities
(n=5145), reported that 62% of their subjects lost weight (Wing et al., 2011). Interestingly, a
yearlong lifestyle intervention on patients with at risk for diabetes reported that participants that
completed the intervention had 44% lower diabetes incidence even if they did not meet the
weight lost goal of 7% (Hamman et al., 2006). The study by Hamman and collaborators (2006)
showed that almost 38% of participants did not lose weight, thus suggesting that even when the
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weight loss is modest or non-existent, the physical activity included in a lifestyle intervention
can result in beneficial health outcomes.
The percentage of body weight loss by BMI categories was noticeably greater among
those classified as obesity class II with 1.90% (SD±4.34) followed by obesity class I with 1.59%
(SD±4.07) and overweight 1.11% (SD±3.22). The same trend was observed in lifestyle
interventions with Caucasian adults in where participants with class II obesity lost more weight
than those who were classified as class I and overweight (Barte, Veldwijk, Teixeira, Sacks, &
Bemelmans, 2014). Almost half of participants selected according to the 2013 AHA/ACC/TOS
Guidelines showed positive changes in blood pressure, which have been associated with
decreased risk for CVD and mortality in previous studies (Vasan et al., 2001).
The results showed that 19 obese participants did not present the risk factor of large WC.
On an individual basis, it is important to recognize that BMI is a measure of body weight rather
than excess body fat that is why this indicator is used as a screening tool rather than a diagnostic
tool (CDC, 2013). Review committees have selected the WC measurement as an accurate
indicator of other individual and multiple cardiovascular risk factors, hence a measure for
indicating the need for weight management (Dobbelsteyn, Joffres, MacLean, & Flowerdew,
2001; Lean, Han, & Morrison, 1995). The weight losses after the 4-month intervention yielded a
statistically significant mean WC reduction of 3.32 cm. Similarly, The Look AHEAD intensive
lifestyle intervention reported a 6.2 cm WC reduction while the control group in the same study
showed a 0.5 cm reduction after 1 year (Espeland, 2007).
There was no statistically significant difference in BP after the 4-month intervention.
However, a noteworthy observation from the study was a decrease in BP trend in both, SBP and
DBP. Meta-analysis studies report that six months is the weight loss zenith for interventions,
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except for bariatric surgery (Espeland, 2007; Perri, Nezu, Patti, & McCann, 1989; Yanovski &
Yanovski, 2002; Jensen et al., 2013). It is inferred that a longer intervention would result in
more meaningful decreasing BP trends same that can result into a statistically significant change.
Although the mean BP in this study was not statistically significant, 42.1% (120) participants
achieved a clinically significant reduction of 3 mmHg or more, as suggested by literature (Jensen
et al., 2013). Furthermore, the obesity class III group from the current study had a significant
SBP reduction of 6.17 mmHg.
Lastly, the 2013 AHA/ACC/TOS Guidelines state the need to determine the adequate
skills and personal characteristics required to serve in a lifestyle intervention. Browstein and
collaborators (2007) propose that Community Health Workers can bridge the social and cultural
gaps between the health providers and the community; henceforth, aiding to a successful
implementation of community based interventions. The positive results of the study suggest that
for the Hispanic community living in the border region, Community Health Workers/Promotores
de Salud possess the personal characteristics to serve as lifestyle interventionists.
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CHAPTER 7: CONCLUSSION
In conclusion, by applying the 2013 AHA/ACC/TOS Guideline for the Management of
Overweight and Obesity in Adults to a Hispanic population that engaged in the PLMM
intervention it was confirmed that this type of comprehensive intervention offers an efficient
method to manage overweight and obesity among Hispanic adults living in the U.S.-Mexico
border region. The 4-month PLMM intervention demonstrated much better results than programs
that only provide informational weight loss sessions for their patients. The participants that
completed the intervention showed a statistically significant decrease in weight, BMI, and WC.
Other interventions such as the Look AHEAD study have achieved improved results in terms of
weight loss (Wadden et al., 2009). However, when taking into consideration that such studies
have been implemented for at least 3 times the duration of the present study, one can assume that
the PLMM intervention has the potential to improve the health status of participants should the
intervention were to last for a longer period of time and when a diet component is included.
Community Health Workers or Promotores de Salud play an important role in comprehensive
lifestyle intervention programs that include multiple components (heart-health education,
nutrition education and a variety of physical activities) such as the PLMM intervention.
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